Black Knight selling unit to win clearance for acquisition by IntercontinentalExchange

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Black Knight Inc. and Intercontinental Exchange Inc. cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling...

Black Knight Inc. BKI and Intercontinental Exchange Inc. ICE cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CA:CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions.

4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions. The companies said the deal is partly to secure clearance of ICE’s proposed acquisition of Black Knight under the Hart-Scott Rodino Act.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 3. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
La source: MarketWatch - 🏆 3. / 97 Lire la suite »